Finally, using a semi-quantitative IHC assay to assess the intracellular distribution and relative levels of RelA in breast tumor sections and Ki67 as a marker for proliferation, we confirmed the negative correlation between elevated RelA and proliferation in ER+/HER2- tumors. Here, MKI67 is linked to breast neoplasm.